An interventional study of FluidVision AIOL and Cataract surgery in Aphakia, sponsored by PowerVision. Completed at 5 sites in 2 countries. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2021-05-21.
Sponsored by PowerVision · Not applicable, Interventional, and Device feasibility
The purpose of this study is to evaluate the clinical outcomes of an investigational IOL in patients undergoing cataract extraction and intraocular lens implantation using an improved injector system.
Key Inclusion Criteria:
Key Exclusion Criteria:
FluidVision AIOL implanted in the capsular bag of the eye during cataract surgery
Device: FluidVision AIOL · Procedure: Cataract surgery
Investigational implantable medical device intended for long-term use over the lifetime of the cataract subject. An improved injector system was used.
Performed using standard microsurgical techniques
Accommodative amplitude
Accommodative amplitude is a measure of the ability of the eye to focus from a target that is at distance into a target that is near.
Time frame: Month 6
Best corrected distance visual acuity (BCDVA)
Visual acuity of the eye will be tested with the correction in place.
Time frame: Month 6
Rates of adverse events
Adverse events will be collected from time of enrollment to study exit.
Time frame: Up to Month 36
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in May 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
PowerVision